Legend Historical Financial Ratios
| LEGN Stock | USD 47.06 0.87 1.88% |
Legend BiotechCorp is lately reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 349 will help investors to properly organize and evaluate Legend BiotechCorp financial condition quickly.
Legend |
About Legend Financial Ratios Analysis
Legend BiotechCorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Legend BiotechCorp investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Legend financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Legend BiotechCorp history.
Legend BiotechCorp Financial Ratios Chart
Legend BiotechCorp financial ratios usually calculated using numerical values taken directly from Legend BiotechCorp financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Legend BiotechCorp. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Legend BiotechCorp's Cash Per Share is very stable compared to the past year. As of the 23rd of April 2024, Days Payables Outstanding is likely to grow to 48.96, while PTB Ratio is likely to drop 8.04. Add Fundamental
Dividend Yield
Dividend Yield is Legend BiotechCorp dividend as a percentage of Legend BiotechCorp stock price. Legend BiotechCorp dividend yield is a measure of Legend BiotechCorp stock productivity, which can be interpreted as interest rate earned on an Legend BiotechCorp investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Most ratios from Legend BiotechCorp's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Legend BiotechCorp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.At this time, Legend BiotechCorp's Cash Per Share is very stable compared to the past year. As of the 23rd of April 2024, Days Payables Outstanding is likely to grow to 48.96, while PTB Ratio is likely to drop 8.04.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 44.49 | 1.99 | 8.17 | 7.76 | Days Of Inventory On Hand | 2.04 | 57.82 | 43.08 | 45.23 |
Legend BiotechCorp fundamentals Correlations
Click cells to compare fundamentals
Legend BiotechCorp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Legend BiotechCorp fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 85.29 | 43.97 | 73.11 | 67.86 | 37.16 | 70.16 | |
| Ptb Ratio | (39.75) | 11.87 | 13.93 | 10.67 | 8.47 | 8.04 | |
| Days Sales Outstanding | 227.91 | 409.9 | 256.76 | 0.28 | 201.05 | 348.78 | |
| Book Value Per Share | (0.93) | 2.37 | 3.35 | 4.68 | 7.11 | 7.46 | |
| Free Cash Flow Yield | (0.025) | (0.082) | (0.0374) | (0.028) | (0.0478) | (0.0501) | |
| Invested Capital | (0.0495) | 0.012 | 0.26 | 0.38 | 0.23 | 0.18 | |
| Operating Cash Flow Per Share | (0.63) | (1.89) | (1.41) | (1.26) | (2.18) | (2.07) | |
| Stock Based Compensation To Revenue | 0.0222 | 0.0629 | 0.22 | 0.29 | 0.17 | 0.1 | |
| Capex To Depreciation | (7.44) | (5.01) | (3.39) | (1.21) | (5.94) | (6.24) | |
| Pb Ratio | (39.75) | 11.87 | 13.93 | 10.67 | 8.47 | 8.04 | |
| Ev To Sales | 83.94 | 37.99 | 66.81 | 63.57 | 33.83 | 65.49 | |
| Free Cash Flow Per Share | (0.93) | (2.31) | (1.74) | (1.4) | (2.87) | (2.73) | |
| Roic | 1.14 | (1.09) | (0.66) | (0.44) | (0.29) | (0.3) | |
| Net Income Per Share | (1.01) | (2.57) | (2.74) | (2.81) | (2.94) | (3.09) | |
| Sales General And Administrative To Revenue | 0.12 | 0.31 | 0.52 | 0.69 | 0.37 | 0.27 | |
| Research And Ddevelopement To Revenue | 2.83 | 3.07 | 3.49 | 2.87 | 1.34 | 1.98 | |
| Cash Per Share | 1.2 | 4.28 | 6.26 | 6.45 | 7.43 | 7.81 | |
| Pocfratio | (58.8) | (14.92) | (33.08) | (39.69) | (27.56) | (28.94) | |
| Interest Coverage | (586.87) | (74.45) | (436.69) | (42.22) | (20.29) | (21.31) | |
| Capex To Operating Cash Flow | 0.47 | 0.22 | 0.24 | 0.11 | 0.32 | 0.18 | |
| Pfcf Ratio | (39.96) | (12.2) | (26.73) | (35.71) | (20.94) | (21.99) | |
| Income Quality | 0.64 | 0.72 | 0.51 | 0.45 | 0.74 | 0.78 | |
| Roe | 1.08 | (1.08) | (0.82) | (0.6) | (0.41) | (0.43) | |
| Ev To Operating Cash Flow | (57.87) | (12.89) | (30.23) | (37.18) | (25.09) | (26.34) | |
| Pe Ratio | (36.73) | (10.96) | (17.0) | (17.79) | (20.44) | (21.47) | |
| Return On Tangible Assets | (0.47) | (0.42) | (0.35) | (0.34) | (0.31) | (0.32) | |
| Ev To Free Cash Flow | (39.33) | (10.54) | (24.43) | (33.46) | (19.06) | (20.02) | |
| Earnings Yield | (0.0272) | (0.0912) | (0.0588) | (0.0562) | (0.0489) | (0.0514) | |
| Intangibles To Total Assets | 0.0179 | 0.003956 | 0.004188 | 0.002561 | 0.084 | 0.0882 | |
| Current Ratio | 1.62 | 3.68 | 3.39 | 3.69 | 6.92 | 7.27 | |
| Tangible Book Value Per Share | (0.97) | 2.35 | 3.31 | 4.66 | 6.27 | 6.58 | |
| Receivables Turnover | 1.6 | 0.89 | 1.42 | 1.3K | 1.82 | 1.72 | |
| Graham Number | 4.59 | 11.71 | 14.37 | 17.19 | 21.69 | 22.78 | |
| Shareholders Equity Per Share | (0.93) | 2.37 | 3.35 | 4.68 | 7.11 | 7.46 |
Legend BiotechCorp Investors Sentiment
The influence of Legend BiotechCorp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Legend. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Legend BiotechCorp's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend BiotechCorp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Legend BiotechCorp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Legend BiotechCorp's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Legend BiotechCorp's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Legend BiotechCorp.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Legend BiotechCorp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Legend BiotechCorp's short interest history, or implied volatility extrapolated from Legend BiotechCorp options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.